Raghuveer Vedala, MD, FAAFP, DABOM, DABLM, Board-Certified Family Medicine and Obesity Medicine Physician

Brian Lin, PhD, is a Research Portfolio Director at the Muscular Dystrophy Association (MDA), where he oversees research focused on neurology-based diseases within the organization’s portfolio. He earned his PhD from the University of Maryland, Baltimore, studying UBQLN2 mutations in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Dr. Lin completed his postdoctoral training at the U.S. Food and Drug Administration (FDA), where his research focused on gene engineering and the role of synonymous mutations in protein therapeutics and gene therapies. His experience bridging molecular research and regulatory science now informs his work at MDA, where he supports cutting-edge research aimed at accelerating treatments and improving outcomes for individuals living with neuromuscular diseases.